李傳行副主任醫(yī)師
中山大學(xué)附屬腫瘤醫(yī)院影像與微創(chuàng)介入中心
副主任醫(yī)師、碩士導(dǎo)師、醫(yī)學(xué)博士 專業(yè)方向： 腫瘤介入微創(chuàng)治療，放射性粒子組織間植入腫瘤治療 臨床技能： 熟練掌握腫瘤介入相關(guān)知識，應(yīng)用介入導(dǎo)管和影像導(dǎo)向技術(shù)治療頭、頸、胸、腹、盆腔等部位腫瘤，如采用射頻、微波、冷凍技術(shù)消融滅活腫瘤，放射性粒子組織間永久植入及高強度聚焦超聲(HIFU)治療惡性實體腫瘤。同時熟練掌握肝癌的動脈栓塞化療、脾功能亢進介入栓塞治療、子宮肌瘤動脈栓塞微創(chuàng)治療、胰腺癌動脈灌注化療、胃腸腫瘤動脈灌注化療，動脈藥盒導(dǎo)管系統(tǒng)植入術(shù)，氣管或食管內(nèi)支架植入術(shù)，經(jīng)皮肝穿刺膽道內(nèi)外引流及膽道內(nèi)支架植入術(shù)，血管內(nèi)支架植入術(shù)治療上腔靜脈或下腔靜脈阻塞綜合癥，經(jīng)皮穿刺椎體成形術(shù)，經(jīng)皮穿刺活檢術(shù)以及經(jīng)導(dǎo)管DSA血管造影診斷等技術(shù)。 專業(yè)兼職： 中國抗癌協(xié)會腫瘤微創(chuàng)治療專業(yè)委員會委員 中國抗癌協(xié)會粒子治療學(xué)會委員 廣東省抗癌協(xié)會腫瘤影像與介入診治專業(yè)委員會委員 《Surgery》 Reviewer 《Am J Clin Oncol》 Reviewer 《Hepatology International》 Reviewer 近年發(fā)表SCI論文: 第一及通訊作者： 1. Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound. Cancer 2010;116(16):3934-42 2. Reply to high-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas. Cancer 2011;117(15):2822-23. 3. Therapeutic effects and prognostic factors in high-Intensity focused ultrasound combined with chemoembolization for larger hepatocellular carcinoma. Eur J Cancer 2010;46:2513-21. 4. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: Chemoembolization and stent combined with iodine-125 seed. Cancer Biol Ther 2011;10 (12). In press 5. Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136(11):1491-9. 6. Microwave ablation treatment of liver cancer with 2450-MHz cooled-shaft antenna: an experimental and clinical study. J Cancer Res Clin Oncol 2010;136:1507-16 (通訊作者) 7. Osteosarcoma: Limb salvaging treatment by ultrasonographically guided high intensity focused ultrasound. Cancer Biol Ther 2009;8(12):1102-8. 8. Superficial malignant tumors: Non-invasive treatment with ultrasonographically guided high-Intensity focused ultrasound. Cancer Biol Ther 2009;8(24):74-81. 9. Analysis of clinical effect for liver cancer using high intensity focused ultrasound. World J Gastroenterology 2004;10(15):2201-4. 10. A meta-analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorectal cancer. Colorectal Disease 2011. In press. (通訊作者) 11. Microwave ablation: results in ex vivo and in vivo porcine livers with 2450-MHz cooled-shaft antenna. Chin Med J 2011;124. In Press .(通訊作者) 第二作者 13. Short to mid term evaluation of CT-guided 125I brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma.Cancer Biol Ther 2009;8(7):585-90. 14. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: Correlation with histopathologic findings. Eur J Radiol 2011:80: 269-73. 15. CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma. Chin Med J (Engl) 2008; 121(23):2410-4. 第三作者及其他 16. Computed tomography and magnetic resonance imaging findings of peripheral primitive neuroectodermal tumors of the head and neck. Eur J Radiol 2011:80(2):607-11. 17. CT-guided percutaneous microwave ablation of adrenal malignant carcinoma: preliminary results. Cancer 2011:26 18. Comprehensive sequential interventional therapy for hepatocellular carcinoma. Chin Med J(Engl) 2009;122(19):2292-8. 19. Aurora-A down regulates IkappaBalpha via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival. Mol Cancer 2009;8:95. 20. Comprehensive sequential interventional therapy for hepatocellular. carcinoma. Chin Med J (Engl) 2009:5;122(19):2292-8. 參編著作： 1.《2006消化系統(tǒng)腫瘤新進展》北京：人民衛(wèi)生出版社，2006年第1版。 2.《腫瘤介入診療學(xué)》北京：科學(xué)出版社出版，2005年第1版。 科研項目： 1.主持:廣東省自然科學(xué)基金(10451008901006151)，Aurora-A激酶靶向抑制劑VX-680聯(lián)合Sorafenib治療晚期肝癌的機制研究; 2.主持:衛(wèi)生部科研基金(WKJ2006-1-007)，高強度聚焦超聲治療腫瘤綜合評價; 3.主持:廣東省衛(wèi)生廳基金(51205026)，肝細胞癌介入治療分子療效及微轉(zhuǎn)移研究; 4.主持:暨大重點實驗室開放基金(A2006227)，動脈栓塞化療與高強度聚焦超聲聯(lián)合治療肝癌的臨床研究; 5.參研:廣州市科技計劃項目(2007Z3-E0231)，生物可控降解型放射性粒子鏈和匹配的TPS研制及臨床前應(yīng)用研究。 聯(lián)系電話：020-87343381 Fax：020-87343774 出診時間：周三上午
腫瘤介入微創(chuàng)治療，放射性粒子組織間植入腫瘤治療?
